南山樵者的个人主页 - 老虎社区

南山樵者

南山樵者

暂无个人介绍

IP属地：江苏

59关注

3粉丝

0主题

0勋章

2021-07-14

$Hepion Pharmaceuticals, Inc.(HEPA)$利好消息不会有诈吧？还是庄家没准备好？

2020-01-14

$正道集团(01188)$ 动身了！动身了！

2021-06-28

$Hepion Pharmaceuticals, Inc.(HEPA)$这家研发的抗病毒药怎么样啦？会不会一飞冲天

2021-02-16

$Hepion Pharmaceuticals, Inc.(HEPA)$怎停牌啦？

2020-07-30

$Hepion Pharmaceuticals, Inc.(HEPA)$盘整时间差不多了，该冲啦！

2020-03-06

$Restorbio Inc.(TORC)$这家公司以前有个药不就是针对老年人肺炎的，这次怎么不整一整？

2020-01-01

$Infinity Pharmaceuticals(INFI)$ 这个地儿人这么稀？

2020-12-05

$Hepion Pharmaceuticals, Inc.(HEPA)$现在入手等于买的原始股

2021-04-04

$Hepion Pharmaceuticals, Inc.(HEPA)$搞个新药成功很不容易啊

2021-04-04

这是什么意思？

BRIEF-Hepion Pharmaceuticals Files For Mixed Shelf Of Up To $350 Million<blockquote>简介-Hepion Pharmaceuticals申请高达3.5亿美元的混合货架</blockquote>

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3448658753826017","uuid":"3448658753826017","gmtCreate":1485564733656,"gmtModify":1607138273514,"name":"南山樵者","pinyin":"nsqznanshanqiaozhe","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/9cd5612aeadab3c15ab3c2b557efb907","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":3,"headSize":59,"tweetSize":23,"questionSize":0,"limitLevel":900,"accountStatus":3,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-4","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"明星虎友","description":"加入老虎社区2000天","bigImgUrl":"https://static.tigerbbs.com/dddf24b906c7011de2617d4fb3f76987","smallImgUrl":"https://static.tigerbbs.com/53d58ad32c97254c6f74db8b97e6ec49","grayImgUrl":"https://static.tigerbbs.com/6304700d92ad91c7a33e2e92ec32ecc1","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.07.22","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001}],"userBadgeCount":1,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":"江苏","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":145262616,"gmtCreate":1626226065635,"gmtModify":1626226065635,"author":{"id":"3448658753826017","authorId":"3448658753826017","name":"南山樵者","avatar":"https://static.tigerbbs.com/9cd5612aeadab3c15ab3c2b557efb907","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3448658753826017","idStr":"3448658753826017"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/HEPA\">$Hepion Pharmaceuticals, Inc.(HEPA)$</a>利好消息不会有诈吧？还是庄家没准备好？","listText":"<a href=\"https://laohu8.com/S/HEPA\">$Hepion Pharmaceuticals, Inc.(HEPA)$</a>利好消息不会有诈吧？还是庄家没准备好？","text":"$Hepion Pharmaceuticals, Inc.(HEPA)$利好消息不会有诈吧？还是庄家没准备好？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":1,"link":"https://laohu8.com/post/145262616","isVote":1,"tweetType":1,"viewCount":6562,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":127874239,"gmtCreate":1624844713621,"gmtModify":1624844713621,"author":{"id":"3448658753826017","authorId":"3448658753826017","name":"南山樵者","avatar":"https://static.tigerbbs.com/9cd5612aeadab3c15ab3c2b557efb907","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3448658753826017","idStr":"3448658753826017"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/HEPA\">$Hepion Pharmaceuticals, Inc.(HEPA)$</a>这家研发的抗病毒药怎么样啦？会不会一飞冲天","listText":"<a href=\"https://laohu8.com/S/HEPA\">$Hepion Pharmaceuticals, Inc.(HEPA)$</a>这家研发的抗病毒药怎么样啦？会不会一飞冲天","text":"$Hepion Pharmaceuticals, Inc.(HEPA)$这家研发的抗病毒药怎么样啦？会不会一飞冲天","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/127874239","isVote":1,"tweetType":1,"viewCount":4287,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":349310494,"gmtCreate":1617541064918,"gmtModify":1617541064918,"author":{"id":"3448658753826017","authorId":"3448658753826017","name":"南山樵者","avatar":"https://static.tigerbbs.com/9cd5612aeadab3c15ab3c2b557efb907","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3448658753826017","idStr":"3448658753826017"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/HEPA\">$Hepion Pharmaceuticals, Inc.(HEPA)$</a>搞个新药成功很不容易啊","listText":"<a href=\"https://laohu8.com/S/HEPA\">$Hepion Pharmaceuticals, Inc.(HEPA)$</a>搞个新药成功很不容易啊","text":"$Hepion Pharmaceuticals, Inc.(HEPA)$搞个新药成功很不容易啊","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/349310494","isVote":1,"tweetType":1,"viewCount":2865,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":349310895,"gmtCreate":1617540992317,"gmtModify":1617540992317,"author":{"id":"3448658753826017","authorId":"3448658753826017","name":"南山樵者","avatar":"https://static.tigerbbs.com/9cd5612aeadab3c15ab3c2b557efb907","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3448658753826017","idStr":"3448658753826017"},"themes":[],"htmlText":"这是什么意思？","listText":"这是什么意思？","text":"这是什么意思？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/349310895","repostId":"2124393756","repostType":2,"repost":{"id":"2124393756","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1617391696,"share":"https://www.laohu8.com/m/news/2124393756?lang=zh_CN&edition=full","pubTime":"2021-04-03 03:28","market":"us","language":"en","title":"BRIEF-Hepion Pharmaceuticals Files For Mixed Shelf Of Up To $350 Million<blockquote>简介-Hepion Pharmaceuticals申请高达3.5亿美元的混合货架</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=2124393756","media":"Reuters","summary":"April 2 (Reuters) - Hepion Pharmaceuticals Inc   :   * HEPION PHARMACEUTICALS FILES FOR MIXED SHELF ","content":"<p><html><body>April 2 (Reuters) - Hepion Pharmaceuticals Inc   :</p><p><blockquote><html><body>路透4月2日-Hepion Pharmaceuticals Inc：</body></html></blockquote></p><p>   * HEPION PHARMACEUTICALS FILES FOR MIXED SHELF OF UP TO $350 MILLION - SEC FILING</p><p><blockquote>*HEPION PHARMACEUTICALS申请高达3.5亿美元的混合货架-SEC备案</blockquote></p><p>Source text: () Further company coverage:   </p><p><blockquote>源文本：()更多公司报道：</blockquote></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p><p><blockquote>（（Reuters.Briefs@thomsonreuters.com；））</blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Hepion Pharmaceuticals Files For Mixed Shelf Of Up To $350 Million<blockquote>简介-Hepion Pharmaceuticals申请高达3.5亿美元的混合货架</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Hepion Pharmaceuticals Files For Mixed Shelf Of Up To $350 Million<blockquote>简介-Hepion Pharmaceuticals申请高达3.5亿美元的混合货架</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2021-04-03 03:28</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p><html><body>April 2 (Reuters) - Hepion Pharmaceuticals Inc   :</p><p><blockquote><html><body>路透4月2日-Hepion Pharmaceuticals Inc：</body></html></blockquote></p><p>   * HEPION PHARMACEUTICALS FILES FOR MIXED SHELF OF UP TO $350 MILLION - SEC FILING</p><p><blockquote>*HEPION PHARMACEUTICALS申请高达3.5亿美元的混合货架-SEC备案</blockquote></p><p>Source text: () Further company coverage:   </p><p><blockquote>源文本：()更多公司报道：</blockquote></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p><p><blockquote>（（Reuters.Briefs@thomsonreuters.com；））</blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CGEM":"Cullinan Therapeutics","LABP":"Landos Biopharma, Inc.","HEPA":"Hepion Pharmaceuticals, Inc.","SANA":"Sana Biotechnology, Inc.","LHDX":"Lucira Health, Inc."},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2124393756","content_text":"April 2 (Reuters) - Hepion Pharmaceuticals Inc   :   * HEPION PHARMACEUTICALS FILES FOR MIXED SHELF OF UP TO $350 MILLION - SEC FILINGSource text: () Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","news_type":1,"symbols_score_info":{"HEPA":0.9,"SANA":0.82,"LHDX":0.82,"LABP":0.82,"APR":0.82,"CGEM":0.82}},"isVote":1,"tweetType":1,"viewCount":3146,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":382481873,"gmtCreate":1613475425092,"gmtModify":1613475425092,"author":{"id":"3448658753826017","authorId":"3448658753826017","name":"南山樵者","avatar":"https://static.tigerbbs.com/9cd5612aeadab3c15ab3c2b557efb907","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3448658753826017","idStr":"3448658753826017"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/HEPA\">$Hepion Pharmaceuticals, Inc.(HEPA)$</a>怎停牌啦？","listText":"<a href=\"https://laohu8.com/S/HEPA\">$Hepion Pharmaceuticals, Inc.(HEPA)$</a>怎停牌啦？","text":"$Hepion Pharmaceuticals, Inc.(HEPA)$怎停牌啦？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/382481873","isVote":1,"tweetType":1,"viewCount":5081,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":388762092,"gmtCreate":1613098455916,"gmtModify":1613098455916,"author":{"id":"3448658753826017","authorId":"3448658753826017","name":"南山樵者","avatar":"https://static.tigerbbs.com/9cd5612aeadab3c15ab3c2b557efb907","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3448658753826017","idStr":"3448658753826017"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/INFI\">$Infinity Pharmaceuticals(INFI)$</a>投资者来来去去，我陪你五年啦！还会陪你走一段！","listText":"<a href=\"https://laohu8.com/S/INFI\">$Infinity Pharmaceuticals(INFI)$</a>投资者来来去去，我陪你五年啦！还会陪你走一段！","text":"$Infinity Pharmaceuticals(INFI)$投资者来来去去，我陪你五年啦！还会陪你走一段！","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/388762092","isVote":1,"tweetType":1,"viewCount":2421,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":396253278,"gmtCreate":1607134549794,"gmtModify":1703846671675,"author":{"id":"3448658753826017","authorId":"3448658753826017","name":"南山樵者","avatar":"https://static.tigerbbs.com/9cd5612aeadab3c15ab3c2b557efb907","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3448658753826017","idStr":"3448658753826017"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/HEPA\">$Hepion Pharmaceuticals, Inc.(HEPA)$</a>现在入手等于买的原始股","listText":"<a href=\"https://laohu8.com/S/HEPA\">$Hepion Pharmaceuticals, Inc.(HEPA)$</a>现在入手等于买的原始股","text":"$Hepion Pharmaceuticals, Inc.(HEPA)$现在入手等于买的原始股","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/396253278","isVote":1,"tweetType":1,"viewCount":3482,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":979680777,"gmtCreate":1598226222199,"gmtModify":1704217974432,"author":{"id":"3448658753826017","authorId":"3448658753826017","name":"南山樵者","avatar":"https://static.tigerbbs.com/9cd5612aeadab3c15ab3c2b557efb907","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3448658753826017","idStr":"3448658753826017"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/INFI\">$Infinity Pharmaceuticals(INFI)$</a>啥时来个撑杆跳","listText":"<a href=\"https://laohu8.com/S/INFI\">$Infinity Pharmaceuticals(INFI)$</a>啥时来个撑杆跳","text":"$Infinity Pharmaceuticals(INFI)$啥时来个撑杆跳","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/979680777","isVote":1,"tweetType":1,"viewCount":4581,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":947868169,"gmtCreate":1597276491351,"gmtModify":1704215169161,"author":{"id":"3448658753826017","authorId":"3448658753826017","name":"南山樵者","avatar":"https://static.tigerbbs.com/9cd5612aeadab3c15ab3c2b557efb907","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3448658753826017","idStr":"3448658753826017"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/INFI\">$Infinity Pharmaceuticals(INFI)$</a>好事将临，压不住了！","listText":"<a href=\"https://laohu8.com/S/INFI\">$Infinity Pharmaceuticals(INFI)$</a>好事将临，压不住了！","text":"$Infinity Pharmaceuticals(INFI)$好事将临，压不住了！","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/947868169","isVote":1,"tweetType":1,"viewCount":3355,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":947978982,"gmtCreate":1597186013546,"gmtModify":1704214815359,"author":{"id":"3448658753826017","authorId":"3448658753826017","name":"南山樵者","avatar":"https://static.tigerbbs.com/9cd5612aeadab3c15ab3c2b557efb907","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3448658753826017","idStr":"3448658753826017"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/INFI\">$Infinity Pharmaceuticals(INFI)$</a>量价齐升，好！","listText":"<a href=\"https://laohu8.com/S/INFI\">$Infinity Pharmaceuticals(INFI)$</a>量价齐升，好！","text":"$Infinity Pharmaceuticals(INFI)$量价齐升，好！","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/947978982","isVote":1,"tweetType":1,"viewCount":3896,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":945389579,"gmtCreate":1596457702091,"gmtModify":1704212240100,"author":{"id":"3448658753826017","authorId":"3448658753826017","name":"南山樵者","avatar":"https://static.tigerbbs.com/9cd5612aeadab3c15ab3c2b557efb907","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3448658753826017","idStr":"3448658753826017"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/INFI\">$Infinity Pharmaceuticals(INFI)$</a>今夜又是个不一样的夜","listText":"<a href=\"https://laohu8.com/S/INFI\">$Infinity Pharmaceuticals(INFI)$</a>今夜又是个不一样的夜","text":"$Infinity Pharmaceuticals(INFI)$今夜又是个不一样的夜","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/945389579","isVote":1,"tweetType":1,"viewCount":1576,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":942320935,"gmtCreate":1596089563427,"gmtModify":1704210913588,"author":{"id":"3448658753826017","authorId":"3448658753826017","name":"南山樵者","avatar":"https://static.tigerbbs.com/9cd5612aeadab3c15ab3c2b557efb907","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3448658753826017","idStr":"3448658753826017"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/INFI\">$Infinity Pharmaceuticals(INFI)$</a>不离不弃，一路陪你！","listText":"<a href=\"https://laohu8.com/S/INFI\">$Infinity Pharmaceuticals(INFI)$</a>不离不弃，一路陪你！","text":"$Infinity Pharmaceuticals(INFI)$不离不弃，一路陪你！","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/942320935","isVote":1,"tweetType":1,"viewCount":1739,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":942367731,"gmtCreate":1596089491523,"gmtModify":1704210913247,"author":{"id":"3448658753826017","authorId":"3448658753826017","name":"南山樵者","avatar":"https://static.tigerbbs.com/9cd5612aeadab3c15ab3c2b557efb907","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3448658753826017","idStr":"3448658753826017"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/HEPA\">$Hepion Pharmaceuticals, Inc.(HEPA)$</a>盘整时间差不多了，该冲啦！","listText":"<a href=\"https://laohu8.com/S/HEPA\">$Hepion Pharmaceuticals, Inc.(HEPA)$</a>盘整时间差不多了，该冲啦！","text":"$Hepion Pharmaceuticals, Inc.(HEPA)$盘整时间差不多了，该冲啦！","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/942367731","isVote":1,"tweetType":1,"viewCount":1844,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":942397229,"gmtCreate":1596071892861,"gmtModify":1704210857010,"author":{"id":"3448658753826017","authorId":"3448658753826017","name":"南山樵者","avatar":"https://static.tigerbbs.com/9cd5612aeadab3c15ab3c2b557efb907","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3448658753826017","idStr":"3448658753826017"},"themes":[],"htmlText":"柯达会不会先收购某家药厂？","listText":"柯达会不会先收购某家药厂？","text":"柯达会不会先收购某家药厂？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/942397229","repostId":"2055437028","repostType":2,"repost":{"id":"2055437028","kind":"news","pubTimestamp":1596015689,"share":"https://www.laohu8.com/m/news/2055437028?lang=zh_CN&edition=full","pubTime":"2020-07-29 17:41","market":"hk","language":"zh","title":"柯达转行卖药，曾经破产的胶卷大王，重生后在干什么","url":"https://stock-news.laohu8.com/highlight/detail?id=2055437028","media":"红星新闻","summary":"7月28日，美股盘初，柯达（KODK）股价一度暴涨350%，截至今日凌晨收盘，柯达涨20...","content":"<html><body><div>\n<p>　　<strong><a href=\"https://laohu8.com/S/KODK\">柯达</a>转行卖药，曾经破产的胶卷大王，重生后在干什么</strong></p>\n<p>　　7月28日，美股盘初，柯达(KODK)股价一度暴涨350%，截至今日凌晨收盘，柯达涨205.73%，报8.01美元/股，最新总市值为3.50亿美元。</p>\n<p>　　柯达股价暴涨的原因是公司进军制药行业，它获得了美国政府7.65亿美元的国家贷款以创建柯达制药公司。</p>\n<p>　　红星新闻记者发现，这家曾经破产的百年品牌，经过重组成为一家小型数位影像公司。除了为人熟知的影像类产品，柯达还跨界生产影音和数据存储产品，比如存储卡、无线耳机等，还曾宣布生产手机，展示过平板电脑、无人机等，但其中大部分产品都是品牌授权给其他企业生产。</p>\n<p>　　<strong>柯达获得7.65亿贷款</strong></p>\n<p>　　<strong>转行后医药业务将占40%</strong></p>\n<p>　　据悉，柯达制药公司将生产 “已长期陷入国家性短缺的原料”，一旦该部门全面启动并运行，公司将能生产“高达25%的用于非生物、非抗菌、非专利药品的活性药物原料”，其中就包括美国总统特朗普曾表示能用于治疗冠状病毒，但已被美国食品和药物管理局认定为“治疗新冠效果不佳且副作用较大”的抗疟疾药物――羟氯喹。</p>\n<p>　　柯达首席执行长Jim Continenza表示，柯达的贷款条款与商业贷款类似，必须在25年内偿还。公司将把重点转移到制药原料生产，预计该业务将占到公司整体业务的30%至40%。</p>\n<p>　　这笔贷款来自美国国际发展金融公司(U.S.International Development Finance Corporation)，这是一个类似于银行的政府机构。这是依美国《国防生产法案》(Defense Production Act)发放的第一笔此类贷款。美国政府此前曾援引该法案来加快COVID-19新冠等相关用品的生产。特朗普5月发布命令，允许DFC为控制新冠蔓延提供资金支持，并加强任何相关的国内药物生产供应链。美国提供此项贷款的目标是减少对印度等国家药物进口依赖。</p>\n<p>　　美东时间周二晚间，美国总统特朗普在一场新闻发布会上表示：“我们对《国防生产法》的使用将动员柯达制造仿制药的活性药物成分。”</p>\n<p>　　美国国内的药品生产在上世纪70年代开始从美国转移出去，主要原因是为了节约成本。白宫贸易顾问彼得・纳瓦罗表示，他越来越担心美国在药品生产的关键材料上对外国的依赖。美国目前正在考虑为大约30家公司提供资金，以抗击新冠病毒，保护公众健康。</p>\n<p>　　柯达此前曾短暂涉足医药行业。1988年，柯达以近51亿美元的价格收购了制药商Sterling Drug，1994年将其分割出售。</p>\n<p>　　<strong>曾经破产的胶卷大王</strong></p>\n<p>　　<strong>毁灭于自己的技术之手</strong></p>\n<p>　　柯达曾是全球摄影领域的领头羊，这家诞生于1892年的公司最鼎盛时期有14.5万名员工，1997年2月市值最高达到310亿美元。</p>\n<p>　　如今这个百年品牌不仅转行生产仿制药原料，市值也只剩下3.47亿美元，只有巅峰时期的百分之一。</p>\n<p>　　1975年，柯达发明了世界上第一台数码相机。然而它在柯达内部并没有受到重视。柯达高管们认为数码相机会削弱他们的胶卷业务，认为推出数码相机会迫使公司卷入自己与自己的竞争当中。</p>\n<p>　　《福布斯》杂志曾经指出，柯达员工的薪水与胶片、化学品以及相纸等耗材的销量息息相关。他们认为，卖不出去耗材，他们就没有利润。</p>\n<p>　　诞生于柯达的数码相机最终毁灭了柯达。</p>\n<p>　　从20世纪90年代后期开始，数码相机越来越多，柯达开始艰难生存。自2004年以来，柯达几乎每年都在亏损。柯达已经无法盈利。2007年，柯达先后出售了数码相机业务和医疗成像业务。</p>\n<p>　　2008年，iPhone诞生，手机摄影的普及使得胶片数量直线下降。2012年1月柯达正式申请破产保护。</p>\n<p>　　<strong>复活后在干什么？</strong></p>\n<p>　　<strong>大量产品都品牌授权</strong></p>\n<p>　　2013年，柯达脱离破产保护，重组为一家小型数位影像公司，开始跨界转型。2016年，柯达推出了自己的手机。2017年，柯达开始做杂志。柯达还与多家时尚品牌合作推出了联名产品。</p>\n<p>　　根据公开信息，柯达目前的业务主要集中在影像、影音和数据存储产品。</p>\n<p>　　红星新闻记者在电商平台上搜索“柯达”发现，柯达目前的产品主要包括胶卷、数码相机、数码相框、电子相册、照片打印机、扫描仪、相纸、电池、冲印服务等摄影类；存储卡、连接线、U盘等数据存储类；无线耳机、蓝牙音箱、无线同屏器等影音类；非摄影类产品只有眼镜及镜片。记者没有找到柯达手机。</p>\n<p>　　值得一提的是，许多挂着“柯达”商标的产品都是获得了柯达公司品牌授权的其他公司生产的。</p>\n<p>　　柯达官网显示，品牌授权许可产品包括电池、充电器、手电筒、相机配件、眼镜镜片、喷墨纸、墨水和专用介质、喷墨打印机、即时打印相机以及手机。就连数码相机也是授权其他公司生产。</p>\n<p>　　甚至在国际消费电子展(CES 2018)上，柯达展示的手机、平板电脑、无人机和微型投影仪，也均为授权其他公司生产。</p>\n<p>　　手机和平板电脑是Bullitt Group获得柯达品牌授权后推出的产品；无人机是授权给 Thrust UAV 公司品牌后推出的产品；微型投影仪是授权C+A Global公司生产的产品。</p>\n<p>　　红星新闻记者 袁野 吴丹若</p>\n</div></body></html>","source":"zxjw_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>柯达转行卖药，曾经破产的胶卷大王，重生后在干什么</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n柯达转行卖药，曾经破产的胶卷大王，重生后在干什么\n</h2>\n\n<h4 class=\"meta\">\n\n\n2020-07-29 17:41 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.jwview.com/jingwei/html/07-29/336892.shtml><strong>红星新闻</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>柯达转行卖药，曾经破产的胶卷大王，重生后在干什么\n　　7月28日，美股盘初，柯达(KODK)股价一度暴涨350%，截至今日凌晨收盘，柯达涨205.73%，报8.01美元/股，最新总市值为3.50亿美元。\n　　柯达股价暴涨的原因是公司进军制药行业，它获得了美国政府7.65亿美元的国家贷款以创建柯达制药公司。\n　　红星新闻记者发现，这家曾经破产的百年品牌，经过重组成为一家小型数位影像公司。除了为人熟知...</p>\n\n<a href=\"http://www.jwview.com/jingwei/html/07-29/336892.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"http://www.jwview.com/jingwei/07-29/U789P902T1D336892F104DT20200729174129.jpeg","relate_stocks":{"KODK":"柯达"},"source_url":"http://www.jwview.com/jingwei/html/07-29/336892.shtml","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2055437028","content_text":"柯达转行卖药，曾经破产的胶卷大王，重生后在干什么\n　　7月28日，美股盘初，柯达(KODK)股价一度暴涨350%，截至今日凌晨收盘，柯达涨205.73%，报8.01美元/股，最新总市值为3.50亿美元。\n　　柯达股价暴涨的原因是公司进军制药行业，它获得了美国政府7.65亿美元的国家贷款以创建柯达制药公司。\n　　红星新闻记者发现，这家曾经破产的百年品牌，经过重组成为一家小型数位影像公司。除了为人熟知的影像类产品，柯达还跨界生产影音和数据存储产品，比如存储卡、无线耳机等，还曾宣布生产手机，展示过平板电脑、无人机等，但其中大部分产品都是品牌授权给其他企业生产。\n　　柯达获得7.65亿贷款\n　　转行后医药业务将占40%\n　　据悉，柯达制药公司将生产 “已长期陷入国家性短缺的原料”，一旦该部门全面启动并运行，公司将能生产“高达25%的用于非生物、非抗菌、非专利药品的活性药物原料”，其中就包括美国总统特朗普曾表示能用于治疗冠状病毒，但已被美国食品和药物管理局认定为“治疗新冠效果不佳且副作用较大”的抗疟疾药物――羟氯喹。\n　　柯达首席执行长Jim Continenza表示，柯达的贷款条款与商业贷款类似，必须在25年内偿还。公司将把重点转移到制药原料生产，预计该业务将占到公司整体业务的30%至40%。\n　　这笔贷款来自美国国际发展金融公司(U.S.International Development Finance Corporation)，这是一个类似于银行的政府机构。这是依美国《国防生产法案》(Defense Production Act)发放的第一笔此类贷款。美国政府此前曾援引该法案来加快COVID-19新冠等相关用品的生产。特朗普5月发布命令，允许DFC为控制新冠蔓延提供资金支持，并加强任何相关的国内药物生产供应链。美国提供此项贷款的目标是减少对印度等国家药物进口依赖。\n　　美东时间周二晚间，美国总统特朗普在一场新闻发布会上表示：“我们对《国防生产法》的使用将动员柯达制造仿制药的活性药物成分。”\n　　美国国内的药品生产在上世纪70年代开始从美国转移出去，主要原因是为了节约成本。白宫贸易顾问彼得・纳瓦罗表示，他越来越担心美国在药品生产的关键材料上对外国的依赖。美国目前正在考虑为大约30家公司提供资金，以抗击新冠病毒，保护公众健康。\n　　柯达此前曾短暂涉足医药行业。1988年，柯达以近51亿美元的价格收购了制药商Sterling Drug，1994年将其分割出售。\n　　曾经破产的胶卷大王\n　　毁灭于自己的技术之手\n　　柯达曾是全球摄影领域的领头羊，这家诞生于1892年的公司最鼎盛时期有14.5万名员工，1997年2月市值最高达到310亿美元。\n　　如今这个百年品牌不仅转行生产仿制药原料，市值也只剩下3.47亿美元，只有巅峰时期的百分之一。\n　　1975年，柯达发明了世界上第一台数码相机。然而它在柯达内部并没有受到重视。柯达高管们认为数码相机会削弱他们的胶卷业务，认为推出数码相机会迫使公司卷入自己与自己的竞争当中。\n　　《福布斯》杂志曾经指出，柯达员工的薪水与胶片、化学品以及相纸等耗材的销量息息相关。他们认为，卖不出去耗材，他们就没有利润。\n　　诞生于柯达的数码相机最终毁灭了柯达。\n　　从20世纪90年代后期开始，数码相机越来越多，柯达开始艰难生存。自2004年以来，柯达几乎每年都在亏损。柯达已经无法盈利。2007年，柯达先后出售了数码相机业务和医疗成像业务。\n　　2008年，iPhone诞生，手机摄影的普及使得胶片数量直线下降。2012年1月柯达正式申请破产保护。\n　　复活后在干什么？\n　　大量产品都品牌授权\n　　2013年，柯达脱离破产保护，重组为一家小型数位影像公司，开始跨界转型。2016年，柯达推出了自己的手机。2017年，柯达开始做杂志。柯达还与多家时尚品牌合作推出了联名产品。\n　　根据公开信息，柯达目前的业务主要集中在影像、影音和数据存储产品。\n　　红星新闻记者在电商平台上搜索“柯达”发现，柯达目前的产品主要包括胶卷、数码相机、数码相框、电子相册、照片打印机、扫描仪、相纸、电池、冲印服务等摄影类；存储卡、连接线、U盘等数据存储类；无线耳机、蓝牙音箱、无线同屏器等影音类；非摄影类产品只有眼镜及镜片。记者没有找到柯达手机。\n　　值得一提的是，许多挂着“柯达”商标的产品都是获得了柯达公司品牌授权的其他公司生产的。\n　　柯达官网显示，品牌授权许可产品包括电池、充电器、手电筒、相机配件、眼镜镜片、喷墨纸、墨水和专用介质、喷墨打印机、即时打印相机以及手机。就连数码相机也是授权其他公司生产。\n　　甚至在国际消费电子展(CES 2018)上，柯达展示的手机、平板电脑、无人机和微型投影仪，也均为授权其他公司生产。\n　　手机和平板电脑是Bullitt Group获得柯达品牌授权后推出的产品；无人机是授权给 Thrust UAV 公司品牌后推出的产品；微型投影仪是授权C+A Global公司生产的产品。\n　　红星新闻记者 袁野 吴丹若","news_type":1,"symbols_score_info":{"KODK":1}},"isVote":1,"tweetType":1,"viewCount":1447,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":946958117,"gmtCreate":1595578222139,"gmtModify":1704209495076,"author":{"id":"3448658753826017","authorId":"3448658753826017","name":"南山樵者","avatar":"https://static.tigerbbs.com/9cd5612aeadab3c15ab3c2b557efb907","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3448658753826017","idStr":"3448658753826017"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/INFI\">$Infinity Pharmaceuticals(INFI)$</a>28号公布最新情况，看来很有信心啊","listText":"<a href=\"https://laohu8.com/S/INFI\">$Infinity Pharmaceuticals(INFI)$</a>28号公布最新情况，看来很有信心啊","text":"$Infinity Pharmaceuticals(INFI)$28号公布最新情况，看来很有信心啊","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/946958117","isVote":1,"tweetType":1,"viewCount":1595,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":941959102,"gmtCreate":1594779511706,"gmtModify":1704206776371,"author":{"id":"3448658753826017","authorId":"3448658753826017","name":"南山樵者","avatar":"https://static.tigerbbs.com/9cd5612aeadab3c15ab3c2b557efb907","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3448658753826017","idStr":"3448658753826017"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/INFI\">$Infinity Pharmaceuticals(INFI)$</a>最近一会儿暴涨一会儿暴跌，有点不寻常！","listText":"<a href=\"https://laohu8.com/S/INFI\">$Infinity Pharmaceuticals(INFI)$</a>最近一会儿暴涨一会儿暴跌，有点不寻常！","text":"$Infinity Pharmaceuticals(INFI)$最近一会儿暴涨一会儿暴跌，有点不寻常！","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/941959102","isVote":1,"tweetType":1,"viewCount":1750,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":949456103,"gmtCreate":1594298971302,"gmtModify":1704205031602,"author":{"id":"3448658753826017","authorId":"3448658753826017","name":"南山樵者","avatar":"https://static.tigerbbs.com/9cd5612aeadab3c15ab3c2b557efb907","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3448658753826017","idStr":"3448658753826017"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/INFI\">$Infinity Pharmaceuticals(INFI)$</a>消息没配合出来，这次上涨应该难以持续","listText":"<a href=\"https://laohu8.com/S/INFI\">$Infinity Pharmaceuticals(INFI)$</a>消息没配合出来，这次上涨应该难以持续","text":"$Infinity Pharmaceuticals(INFI)$消息没配合出来，这次上涨应该难以持续","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/949456103","isVote":1,"tweetType":1,"viewCount":1846,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":949562169,"gmtCreate":1594274775451,"gmtModify":1704204864160,"author":{"id":"3448658753826017","authorId":"3448658753826017","name":"南山樵者","avatar":"https://static.tigerbbs.com/9cd5612aeadab3c15ab3c2b557efb907","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3448658753826017","idStr":"3448658753826017"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/INFI\">$Infinity Pharmaceuticals(INFI)$</a>今天为啥暴涨？是开始还是暂动？","listText":"<a href=\"https://laohu8.com/S/INFI\">$Infinity Pharmaceuticals(INFI)$</a>今天为啥暴涨？是开始还是暂动？","text":"$Infinity Pharmaceuticals(INFI)$今天为啥暴涨？是开始还是暂动？","images":[{"img":"https://static.tigerbbs.com/976c14f9d58fda2be36a0b4817cd3126","width":"1080","height":"2102"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/949562169","isVote":1,"tweetType":1,"viewCount":1625,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":981317475,"gmtCreate":1583507822997,"gmtModify":1704350142016,"author":{"id":"3448658753826017","authorId":"3448658753826017","name":"南山樵者","avatar":"https://static.tigerbbs.com/9cd5612aeadab3c15ab3c2b557efb907","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3448658753826017","idStr":"3448658753826017"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TORC\">$Restorbio Inc.(TORC)$</a>这家公司以前有个药不就是针对老年人肺炎的，这次怎么不整一整？","listText":"<a href=\"https://laohu8.com/S/TORC\">$Restorbio Inc.(TORC)$</a>这家公司以前有个药不就是针对老年人肺炎的，这次怎么不整一整？","text":"$Restorbio Inc.(TORC)$这家公司以前有个药不就是针对老年人肺炎的，这次怎么不整一整？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/981317475","isVote":1,"tweetType":1,"viewCount":2183,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":916505327,"gmtCreate":1579616413269,"gmtModify":1704339982930,"author":{"id":"3448658753826017","authorId":"3448658753826017","name":"南山樵者","avatar":"https://static.tigerbbs.com/9cd5612aeadab3c15ab3c2b557efb907","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3448658753826017","idStr":"3448658753826017"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/INFI\">$Infinity Pharmaceuticals(INFI)$</a>&nbsp;好消息来了？","listText":"<a href=\"https://laohu8.com/S/INFI\">$Infinity Pharmaceuticals(INFI)$</a>&nbsp;好消息来了？","text":"$Infinity Pharmaceuticals(INFI)$ 好消息来了？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/916505327","isVote":1,"tweetType":1,"viewCount":2072,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":145262616,"gmtCreate":1626226065635,"gmtModify":1626226065635,"author":{"id":"3448658753826017","authorId":"3448658753826017","name":"南山樵者","avatar":"https://static.tigerbbs.com/9cd5612aeadab3c15ab3c2b557efb907","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3448658753826017","authorIdStr":"3448658753826017"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/HEPA\">$Hepion Pharmaceuticals, Inc.(HEPA)$</a>利好消息不会有诈吧？还是庄家没准备好？","listText":"<a href=\"https://laohu8.com/S/HEPA\">$Hepion Pharmaceuticals, Inc.(HEPA)$</a>利好消息不会有诈吧？还是庄家没准备好？","text":"$Hepion Pharmaceuticals, Inc.(HEPA)$利好消息不会有诈吧？还是庄家没准备好？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":1,"link":"https://laohu8.com/post/145262616","isVote":1,"tweetType":1,"viewCount":6562,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":918213897,"gmtCreate":1578984038819,"gmtModify":1704338565305,"author":{"id":"3448658753826017","authorId":"3448658753826017","name":"南山樵者","avatar":"https://static.tigerbbs.com/9cd5612aeadab3c15ab3c2b557efb907","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3448658753826017","authorIdStr":"3448658753826017"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/01188\">$正道集团(01188)$</a>&nbsp;动身了！动身了！","listText":"<a href=\"https://laohu8.com/S/01188\">$正道集团(01188)$</a>&nbsp;动身了！动身了！","text":"$正道集团(01188)$ 动身了！动身了！","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/918213897","isVote":1,"tweetType":1,"viewCount":2102,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":127874239,"gmtCreate":1624844713621,"gmtModify":1624844713621,"author":{"id":"3448658753826017","authorId":"3448658753826017","name":"南山樵者","avatar":"https://static.tigerbbs.com/9cd5612aeadab3c15ab3c2b557efb907","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3448658753826017","authorIdStr":"3448658753826017"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/HEPA\">$Hepion Pharmaceuticals, Inc.(HEPA)$</a>这家研发的抗病毒药怎么样啦？会不会一飞冲天","listText":"<a href=\"https://laohu8.com/S/HEPA\">$Hepion Pharmaceuticals, Inc.(HEPA)$</a>这家研发的抗病毒药怎么样啦？会不会一飞冲天","text":"$Hepion Pharmaceuticals, Inc.(HEPA)$这家研发的抗病毒药怎么样啦？会不会一飞冲天","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/127874239","isVote":1,"tweetType":1,"viewCount":4287,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":382481873,"gmtCreate":1613475425092,"gmtModify":1613475425092,"author":{"id":"3448658753826017","authorId":"3448658753826017","name":"南山樵者","avatar":"https://static.tigerbbs.com/9cd5612aeadab3c15ab3c2b557efb907","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3448658753826017","authorIdStr":"3448658753826017"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/HEPA\">$Hepion Pharmaceuticals, Inc.(HEPA)$</a>怎停牌啦？","listText":"<a href=\"https://laohu8.com/S/HEPA\">$Hepion Pharmaceuticals, Inc.(HEPA)$</a>怎停牌啦？","text":"$Hepion Pharmaceuticals, Inc.(HEPA)$怎停牌啦？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/382481873","isVote":1,"tweetType":1,"viewCount":5081,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":942367731,"gmtCreate":1596089491523,"gmtModify":1704210913247,"author":{"id":"3448658753826017","authorId":"3448658753826017","name":"南山樵者","avatar":"https://static.tigerbbs.com/9cd5612aeadab3c15ab3c2b557efb907","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3448658753826017","authorIdStr":"3448658753826017"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/HEPA\">$Hepion Pharmaceuticals, Inc.(HEPA)$</a>盘整时间差不多了，该冲啦！","listText":"<a href=\"https://laohu8.com/S/HEPA\">$Hepion Pharmaceuticals, Inc.(HEPA)$</a>盘整时间差不多了，该冲啦！","text":"$Hepion Pharmaceuticals, Inc.(HEPA)$盘整时间差不多了，该冲啦！","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/942367731","isVote":1,"tweetType":1,"viewCount":1844,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":981317475,"gmtCreate":1583507822997,"gmtModify":1704350142016,"author":{"id":"3448658753826017","authorId":"3448658753826017","name":"南山樵者","avatar":"https://static.tigerbbs.com/9cd5612aeadab3c15ab3c2b557efb907","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3448658753826017","authorIdStr":"3448658753826017"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TORC\">$Restorbio Inc.(TORC)$</a>这家公司以前有个药不就是针对老年人肺炎的，这次怎么不整一整？","listText":"<a href=\"https://laohu8.com/S/TORC\">$Restorbio Inc.(TORC)$</a>这家公司以前有个药不就是针对老年人肺炎的，这次怎么不整一整？","text":"$Restorbio Inc.(TORC)$这家公司以前有个药不就是针对老年人肺炎的，这次怎么不整一整？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/981317475","isVote":1,"tweetType":1,"viewCount":2183,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":911093235,"gmtCreate":1577878371027,"gmtModify":1704336528221,"author":{"id":"3448658753826017","authorId":"3448658753826017","name":"南山樵者","avatar":"https://static.tigerbbs.com/9cd5612aeadab3c15ab3c2b557efb907","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3448658753826017","authorIdStr":"3448658753826017"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/INFI\">$Infinity Pharmaceuticals(INFI)$</a>&nbsp;这个地儿人这么稀？","listText":"<a href=\"https://laohu8.com/S/INFI\">$Infinity Pharmaceuticals(INFI)$</a>&nbsp;这个地儿人这么稀？","text":"$Infinity Pharmaceuticals(INFI)$ 这个地儿人这么稀？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/911093235","isVote":1,"tweetType":1,"viewCount":3228,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3527667803686145","authorId":"3527667803686145","name":"社区成长助手","avatar":"https://static.tigerbbs.com/2b7c7106b5c0c8b0037faa67439d898f","crmLevel":1,"crmLevelSwitch":0,"idStr":"3527667803686145","authorIdStr":"3527667803686145"},"content":"终于等到了您的初发帖[比心]，虎妞已给你送上100虎币，请前往商城领取；希望您能在老虎社区玩得开心、赚得开心哦； 此外如果您想创作优质文章，这里有一份老虎社区创作指引给到您，希望能对您有帮助！","text":"终于等到了您的初发帖[比心]，虎妞已给你送上100虎币，请前往商城领取；希望您能在老虎社区玩得开心、赚得开心哦； 此外如果您想创作优质文章，这里有一份老虎社区创作指引给到您，希望能对您有帮助！","html":"终于等到了您的初发帖[比心]，虎妞已给你送上100虎币，请前往商城领取；希望您能在老虎社区玩得开心、赚得开心哦； 此外如果您想创作优质文章，这里有一份老虎社区创作指引给到您，希望能对您有帮助！"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":396253278,"gmtCreate":1607134549794,"gmtModify":1703846671675,"author":{"id":"3448658753826017","authorId":"3448658753826017","name":"南山樵者","avatar":"https://static.tigerbbs.com/9cd5612aeadab3c15ab3c2b557efb907","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3448658753826017","authorIdStr":"3448658753826017"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/HEPA\">$Hepion Pharmaceuticals, Inc.(HEPA)$</a>现在入手等于买的原始股","listText":"<a href=\"https://laohu8.com/S/HEPA\">$Hepion Pharmaceuticals, Inc.(HEPA)$</a>现在入手等于买的原始股","text":"$Hepion Pharmaceuticals, Inc.(HEPA)$现在入手等于买的原始股","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/396253278","isVote":1,"tweetType":1,"viewCount":3482,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":349310494,"gmtCreate":1617541064918,"gmtModify":1617541064918,"author":{"id":"3448658753826017","authorId":"3448658753826017","name":"南山樵者","avatar":"https://static.tigerbbs.com/9cd5612aeadab3c15ab3c2b557efb907","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3448658753826017","authorIdStr":"3448658753826017"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/HEPA\">$Hepion Pharmaceuticals, Inc.(HEPA)$</a>搞个新药成功很不容易啊","listText":"<a href=\"https://laohu8.com/S/HEPA\">$Hepion Pharmaceuticals, Inc.(HEPA)$</a>搞个新药成功很不容易啊","text":"$Hepion Pharmaceuticals, Inc.(HEPA)$搞个新药成功很不容易啊","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/349310494","isVote":1,"tweetType":1,"viewCount":2865,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":349310895,"gmtCreate":1617540992317,"gmtModify":1617540992317,"author":{"id":"3448658753826017","authorId":"3448658753826017","name":"南山樵者","avatar":"https://static.tigerbbs.com/9cd5612aeadab3c15ab3c2b557efb907","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3448658753826017","authorIdStr":"3448658753826017"},"themes":[],"htmlText":"这是什么意思？","listText":"这是什么意思？","text":"这是什么意思？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/349310895","repostId":"2124393756","repostType":2,"repost":{"id":"2124393756","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1617391696,"share":"https://www.laohu8.com/m/news/2124393756?lang=zh_CN&edition=full","pubTime":"2021-04-03 03:28","market":"us","language":"en","title":"BRIEF-Hepion Pharmaceuticals Files For Mixed Shelf Of Up To $350 Million<blockquote>简介-Hepion Pharmaceuticals申请高达3.5亿美元的混合货架</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=2124393756","media":"Reuters","summary":"April 2 (Reuters) - Hepion Pharmaceuticals Inc   :   * HEPION PHARMACEUTICALS FILES FOR MIXED SHELF ","content":"<p><html><body>April 2 (Reuters) - Hepion Pharmaceuticals Inc   :</p><p><blockquote><html><body>路透4月2日-Hepion Pharmaceuticals Inc：</body></html></blockquote></p><p>   * HEPION PHARMACEUTICALS FILES FOR MIXED SHELF OF UP TO $350 MILLION - SEC FILING</p><p><blockquote>*HEPION PHARMACEUTICALS申请高达3.5亿美元的混合货架-SEC备案</blockquote></p><p>Source text: () Further company coverage:   </p><p><blockquote>源文本：()更多公司报道：</blockquote></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p><p><blockquote>（（Reuters.Briefs@thomsonreuters.com；））</blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Hepion Pharmaceuticals Files For Mixed Shelf Of Up To $350 Million<blockquote>简介-Hepion Pharmaceuticals申请高达3.5亿美元的混合货架</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Hepion Pharmaceuticals Files For Mixed Shelf Of Up To $350 Million<blockquote>简介-Hepion Pharmaceuticals申请高达3.5亿美元的混合货架</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2021-04-03 03:28</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p><html><body>April 2 (Reuters) - Hepion Pharmaceuticals Inc   :</p><p><blockquote><html><body>路透4月2日-Hepion Pharmaceuticals Inc：</body></html></blockquote></p><p>   * HEPION PHARMACEUTICALS FILES FOR MIXED SHELF OF UP TO $350 MILLION - SEC FILING</p><p><blockquote>*HEPION PHARMACEUTICALS申请高达3.5亿美元的混合货架-SEC备案</blockquote></p><p>Source text: () Further company coverage:   </p><p><blockquote>源文本：()更多公司报道：</blockquote></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p><p><blockquote>（（Reuters.Briefs@thomsonreuters.com；））</blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CGEM":"Cullinan Therapeutics","LABP":"Landos Biopharma, Inc.","HEPA":"Hepion Pharmaceuticals, Inc.","SANA":"Sana Biotechnology, Inc.","LHDX":"Lucira Health, Inc."},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2124393756","content_text":"April 2 (Reuters) - Hepion Pharmaceuticals Inc   :   * HEPION PHARMACEUTICALS FILES FOR MIXED SHELF OF UP TO $350 MILLION - SEC FILINGSource text: () Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","news_type":1,"symbols_score_info":{"HEPA":0.9,"SANA":0.82,"LHDX":0.82,"LABP":0.82,"APR":0.82,"CGEM":0.82}},"isVote":1,"tweetType":1,"viewCount":3146,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}